PTX
Click for more information
0.00% 4.0¢ prescient therapeutics limited

Ann: Interim Durability Analysis of PTX-200 Breast Cancer Study, page-44

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
TRADE NOW
TRADE NOW
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
TRADE NOW
  1. Eagleman79
    423 Posts.
    lightbulb Created with Sketch. 21
    clock Created with Sketch.
    11/12/18
    12:34
    Post #: 36818203
    I’m totally perplexed by this , I bought in earlier this year on the merits of the board and their progress to date ... after reading yesterday’s release I was convinced we would see some confidence return to the market... and now this

    The SP definitely isn’t reflecting the quality of yesterday’s announcement, especially when you consider the progress already made with this drug ...
    PTX Price at posting: 7.2¢ Sentiment: None Disclosure: Not Held
    Likes Created with Sketch. 3  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 
watchlist Created with Sketch. Add PTX (ASX) to my watchlist
(20min delay)
Last
4.0¢ 		Change
0.000(0.00%) 		Mkt cap ! $32.21M
Open High Low Value Volume
4.0¢ 4.1¢ 4.0¢ $22.35K 558.4K

Buyers (Bids)

No. Vol. Price($)
6 221774 3.9¢
 

Sellers (Offers)

Price($) Vol. No.
4.1¢ 860576 3
View Market Depth
Last trade - 14.51pm 19/11/2024 (20 minute delay) ?
PTX (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.